News & Analysis as of

Machine Learning Risk Management Today's Popular Updates

Troutman Pepper Locke

Cleared for Takeoff? Copilot Legal and Technical Preflight Checklist

Troutman Pepper Locke on

Millions of companies use the Microsoft 365 suite of tools every day to create, communicate, and collaborate, but far fewer have adequately grappled with the legal risks introduced by Copilot, the powerful generative AI...more

HaystackID

New AI, New Risks: Inside GenAI’s Cybersecurity Dilemma

HaystackID on

Generative artificial intelligence, once the subject of experimental labs and speculative fiction, is now a central force in digital transformation, and cybersecurity professionals are finding themselves on unfamiliar ground....more

Davis Wright Tremaine LLP

NSA Issues Cybersecurity Guidance and Best Practices for AI Systems

The National Security Agency (NSA), in coordination with the Cybersecurity and Infrastructure Security Agency (CISA), the Federal Bureau of Investigation (FBI) and cybersecurity agencies from Australia, New Zealand, and the...more

Foley & Lardner LLP

HIPAA Compliance Risks with AI Scribes in Health Care: What Digital Health Leaders Need to Know

Foley & Lardner LLP on

AI scribes are quickly becoming the digital sidekick of modern health care. They promise to reduce clinician burnout, streamline documentation, and improve the patient experience. But as health care providers and digital...more

Loeb & Loeb LLP

Court Orders OpenAI to Retain All Output Log Data: Considerations for ChatGPT Users

Loeb & Loeb LLP on

In the ongoing copyright infringement case brought by The New York Times against OpenAI and Microsoft (The New York Times Company v. Microsoft Corporation et al., Case No. 1:23-cv-11195 (S.D.N.Y.)), Judge Ona T. Wang recently...more

Mitchell, Williams, Selig, Gates & Woodyard,...

Artificial Intelligence/Generative AI's Environmental and Human Effects: April 22nd U.S. GAO Report

The United States Government Accountability Office (“GAO”) released on April 22nd a report titled: Artificial Intelligence: Generative AI's Environmental and Human Effects (“Report”). See GAO-25-107172....more

Rumberger | Kirk

What DeepSeek Can Teach Legal Teams About Creating Stronger GenAI Policies

Rumberger | Kirk on

The instant popularity of China’s DeepSeek-V3 generative artificial intelligence model underscores why companies should craft stronger GenAI policies that minimize the risks of employees exposing sensitive data, violating...more

K2 Integrity

Navigating AI Governance and Security in the Age of Generative AI

K2 Integrity on

On 26 March 2025, K2 Integrity hosted a webinar discussing generative AI, its associated risks, governance strategies, and the future trajectory of AI adoption. The webinar featured Jason Straight, senior managing director...more

Osano

AI Governance & Why It Is Necessary

Osano on

In March 2023, Elon Musk and Steve Wozniak, along with other technology experts, signed an open letter asking that training powerful AI models be stopped until stronger AI governance laws could be developed. Two months later,...more

Baker Donelson

Top Five AI Procurement Questions General Counsel for Manufacturers Should Consider

Baker Donelson on

Artificial intelligence (AI) is reshaping the future of manufacturing. As manufacturing operations shift back to the U.S. in response to recent tariff policies, general counsels (GCs) in the manufacturing sector face a...more

Faegre Drinker Biddle & Reath LLP

DHS Playbook for Public Sector GenAI Deployment – Insights for the Private Sector

In January 2025, the Department of Homeland Security (DHS) released its “Playbook for Public Sector Generative Artificial Intelligence Deployment” (the “Playbook”). The Playbook provides valuable insights and actionable steps...more

J.S. Held

2025 J.S. Held Global Risk Report: Artificial Intelligence, Data & Digital Regulations

J.S. Held on

Artificial Intelligence (AI) has been touted as the answer to a multitude of business challenges. However, AI – along with machine learning and large language models (LLMs) – is still fraught with technical and regulatory...more

StoneTurn

2025 and Cybersecurity: What is Your Strategy?

StoneTurn on

Cybersecurity in 2025 will continue to face escalating challenges from AI-driven threats, geopolitical tensions, and increased regulatory scrutiny. Organizations must adapt to sophisticated cyberattacks fueled by AI,...more

U.S. Legal Support

The Evolution of AI in Litigation

U.S. Legal Support on

Although occasional murmurings about general AI reached the public during the 2010s, it was ChatGPT’s November ‘22 entrance onto the global stage that officially introduced the world to artificial intelligence....more

Frost Brown Todd

Managing Data Security and Privacy Risks in Enterprise AI

Frost Brown Todd on

Artificial intelligence (AI), particularly generative AI, thrives on vast amounts of data, fueling AI capabilities, insights, and predictions. But with this reliance on data comes potential privacy and security risks. And...more

Purpose Legal

AI rEvolution – Choosing Generative AI for Document Review? Don’t Overthink It!

Purpose Legal on

Recently, while preparing for an upcoming panel presentation at the ASU Arkfeld eDiscovery, Law and Technology Conference on March 11 and 12 (Learn more about the conference HERE), my co-panelists and I were discussing...more

Hanzo

Chat eDiscovery, Reimagined: Why Gen AI is the Smarter Way to Handle Chat Data

Hanzo on

Imagine searching for a crucial conversation in a sea of endless chat messages—messages filled with greetings, status updates, and casual banter. The reality of modern enterprise communication is an overwhelming flood of...more

Mintz - Intellectual Property Viewpoints

Patenting AI/ML Life Sciences and TechBio Innovations – How Much Disclosure is Sufficient?

In recent years, the rapid advancement of artificial intelligence (AI) and machine learning (ML) technologies has sparked a wave of innovation across various sectors, particularly in life sciences. ML technologies have...more

Kilpatrick

5 Key Takeaways | Managing the Risks in Using Generative AI or How I Learned to Stop Worrying and Love AI

Kilpatrick on

Kilpatrick's Steve Borgman and Jordan Glassman recently presented on the various generative AI technologies available, with an emphasis on large language models such as ChatGPT (and others that are similar), at Kilpatrick’s...more

Cimplifi

Chess, Not Checkers: Strategic Planning and Early Case Assessment in Complex Litigation

Cimplifi on

In order to effectively manage complex litigation, you need to know what success looks like. There are different measures of success beyond the outcome of the litigation and it’s important to identify those success factors...more

Baker Botts L.L.P.

What is DeepSeek, and why does it matter?

Baker Botts L.L.P. on

Everyone seems to be talking about DeepSeek, and its latest AI technologies. But what is DeepSeek? What has it produced? And why is everyone talking about them? This client update is intended to provide some of the basic...more

BCLP

AI and Machine Learning in Financial Crime Compliance

BCLP on

As financial crime risks evolve, including those risks posed by the use of AI and other emerging technologies, so too must firms’ financial crime compliance response. It is unsurprising, therefore, that AI forms part of both...more

Hogan Lovells

Cybersecurity researchers discover “Bad Likert Judge,” a new AI jailbreaking technique

Hogan Lovells on

The “Bad Likert Judge” jailbreaking technique boasts a high attack success rate by using a three-step approach which employs the target LLM’s own understanding of harmful content to bypass the target LLM’s safety guardrails....more

Foley & Lardner LLP

AI Drug Development: FDA Releases Draft Guidance

Foley & Lardner LLP on

On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products...more

Sterne, Kessler, Goldstein & Fox P.L.L.C.

FDA Issues Draft Guidance Documents on Artificial Intelligence for Medical Devices, Drugs, and Biological Products

FDA recently issued two draft guidance documents discussing: (1) the use of artificial intelligence (AI) to produce information to support a regulatory decision about a drug or biological product’s safety, effectiveness, or...more

95 Results
 / 
View per page
Page: of 4

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide